Abbas Torki, Saheb, Roumi, Zahra, Tahavorgar, Atefeh, Salimi, Zahra, Mohammadi, Saeideh, Shekari, Soheila, Saeedirad, Zahra, Amjadi, Arezoo, Mirzaee, Pouya et al (2024) Effect of omega-3 fatty acids supplementation on muscle mass, fat mass, and visceral fat of hemodialysis patients; A randomized clinical trial. Journal of Basic and Clinical Physiology and Pharmacology .
PDF (AAM)
- Accepted Version
Restricted to Repository staff only until 14 November 2025. Available under License Creative Commons Attribution Non-commercial. 429kB |
Official URL: https://doi.org/10.1515/jbcpp-2024-0148
Abstract
Objectives
Several studies demonstrated the benefits of omega-3 fatty acids supplementation in chronic kidney disease (CKD) patients. The objective of this study was to investigate the effect of omega-3 fatty acids supplementation in body composition, specifically on the lean body mass and fat mass in hemodialysis patients.
Methods
In this randomized, double-blind, placebo-controlled clinical trial, a total of 120 end-stage renal disease (ESRD) patients were randomly allocated into two groups. The intervention group has taken three grams of omega-3 fatty acids daily while the placebo group received three grams of medium chain triglycerides (MCT) as a placebo for a total of 2 months. The changes in the body mass index (BMI) and body composition (fat mass, muscle, and visceral fat) were assessed at baseline and following the intervention.
Results
No significant difference was found in the mean of BMI, FAT, muscle, and visceral fat in the intervention group compared to the control group after the intervention. After two months of omega-3 fatty acid supplementation, the study found no statistically significant impact of omega-3 fatty acids supplementation on various indices of body composition. The effect of ω-3 supplementation in reducing visceral fat was close to significant (p=0.08).
Conclusions
This study suggests that there is currently inadequate evidence to support the effect of omega-3 fatty acid supplementation in improving anthropometric measurements in patients with CKD, except a partial effect on visceral fat. Further large-scale and long-term clinical trials are needed to confirm the present results.
Repository Staff Only: item control page